Champlain Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Champlain Investment Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-241,823	Closed	-$27.6M	–	147
2015 Q1	$27.6M	Sell	241,823 -72,234	-23%	-$8.24M	0.47%	94
2014 Q4	$34.6M	Sell	314,057 -64,030	-17%	-$6.75M	0.55%	87
2014 Q3	$36.9M	Buy	378,087 +49,558	+15%	+$4.87M	0.64%	70
2014 Q2	$33.1M	Buy	328,529 +14,739	+5%	+$1.44M	0.54%	83
2014 Q1	$28.8M	Buy	313,790 +18,443	+6%	+$1.7M	0.5%	94
2013 Q4	$26.7M	Buy	295,347 +6,947	+2%	+$601K	0.47%	95
2013 Q3	$23M	Buy	288,400 +10,228	+4%	+$805K	0.44%	95
2013 Q2	$20.2M	Buy	+278,172	New	+$20.8M	0.41%	97

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Champlain Investment Partners's ZBH Position: Q2 2015 in Review

Champlain Investment Partners sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 241,823 shares — an estimated $27.6M sold.

Champlain Investment Partners first reported a position in ZBH in Q2 2013 and held it in 8 quarters. The position peaked at $36.9M in Q3 2014. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

Champlain Investment Partners reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
Champlain Investment Partners sold 241,823 Zimmer Biomet shares in Q2 2015, an estimated $27.6M.
Champlain Investment Partners first reported a position in Zimmer Biomet in Q2 2013 and held it in 8 quarters.
Champlain Investment Partners's Zimmer Biomet position peaked at $36.9M in Q3 2014.
749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Champlain Investment Partners's 13F filing for Q2 2015, filed 12 Aug 2015.